BMC Health Services Research (Dec 2022)

At-home blood self-sampling in rheumatology: a qualitative study with patients and health care professionals

  • Felix Muehlensiepen,
  • Susann May,
  • Joshua Zarbl,
  • Ekaterina Vogt,
  • Katharina Boy,
  • Martin Heinze,
  • Sebastian Boeltz,
  • Hannah Labinsky,
  • Gerlinde Bendzuck,
  • Marianne Korinth,
  • Corinna Elling-Audersch,
  • Nicolas Vuillerme,
  • Georg Schett,
  • Gerhard Krönke,
  • Johannes Knitza

DOI
https://doi.org/10.1186/s12913-022-08787-5
Journal volume & issue
Vol. 22, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Background The goal of the study was to investigate patients’ with systemic rheumatic diseases and healthcare professionals’ experiences and preferences regarding self-sampling of capillary blood in rheumatology care. Methods Patients performed a supervised and consecutive unsupervised capillary blood self-collection using an upper arm based device. Subsequently, patients (n = 15) and their attending health care professionals (n = 5) participated in an explorative, qualitative study using problem-centered, telephone interviews. Interview data were analyzed using structured qualitative content analysis. Results Interviewed patients reported easy application and high usability. Patients and health care professionals alike reported time and cost savings, increased independence and flexibility, improved monitoring and reduction of risk of infection during Covid-19 as benefits. Reported drawbacks include limited blood volume, limited usability in case of functional restrictions, and environmental concerns. Older, immobile patients with long journeys to traditional blood collection sites and young patients with little time to spare for traditional blood collection appointments could be user groups, likely to benefit from self-sampling services. Conclusions At-home blood self-sampling could effectively complement current rheumatology telehealth care. Appropriateness and value of this service needs to be carefully discussed with patients on an individual basis. Trial Registration WHO International Clinical Trials Registry: DRKS00024925. Registered on 15/04/2021.

Keywords